Overview
Pharmacokinetics and Safety Profile of CKD-333
Status:
Completed
Completed
Trial end date:
2018-10-12
2018-10-12
Target enrollment:
0
0
Participant gender:
Male
Male
Summary
Compare the pharmacokinetic characteristics and safety between CKD-333 tablet and CKD-330, D086 combinationPhase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Criteria
Inclusion Criteria:1. Between 19 aged and 45 aged in healthy male adult
2. Body weight more than 50kg and within ideal body weight ±20%
Exclusion Criteria:
1. Have clinical significant medical history or disease that cardiovascular system,
respiratory system, kidney, endocrine system, hematological system, digestive system ,
mental illness
2. Have a gastrointestinal disease history that can effect drug absorption or surgery
3. SBP(Systolic Blood pressure)≥140mmHg or SBP<90mmHg, DBP(Diastolic Blood
Pressure(≥90mmHg or DBP<60mmHg